Issue navigation
Volume 16, Issue 7, July 2022
Original Articles
Categorising Endoscopic Severity of Crohn’s Disease Using the Modified Multiplier SES-CD [MM-SES-CD]
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1011–1019, https://doi.org/10.1093/ecco-jcc/jjac018
Combined Histo-endoscopic Remission but not Endoscopic Healing Alone in Ulcerative Colitis is Associated with a Mucosal Transcriptional Profile Resembling Healthy Mucosa
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1020–1029, https://doi.org/10.1093/ecco-jcc/jjac001
Smoking Behaviour Changes After Diagnosis of Inflammatory Bowel Disease and Risk of All-cause Mortality
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1030–1038, https://doi.org/10.1093/ecco-jcc/jjac015
Existing Prediction Models of Disease Course in Paediatric Crohn’s Disease Are Poorly Replicated in a Prospective Inception Cohort
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1039–1048, https://doi.org/10.1093/ecco-jcc/jjac005
Management and Long-term Outcomes of Crohn’s Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1049–1058, https://doi.org/10.1093/ecco-jcc/jjac016
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1059–1069, https://doi.org/10.1093/ecco-jcc/jjac009
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1070–1078, https://doi.org/10.1093/ecco-jcc/jjac010
Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn’s Disease in the Era of Biologic Therapy
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1079–1088, https://doi.org/10.1093/ecco-jcc/jjac012
Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1089–1096, https://doi.org/10.1093/ecco-jcc/jjac014
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1097–1109, https://doi.org/10.1093/ecco-jcc/jjac003
The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn’s Disease
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1110–1123, https://doi.org/10.1093/ecco-jcc/jjac008
Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn’s Disease Through the ATX–LPA Axis
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1124–1139, https://doi.org/10.1093/ecco-jcc/jjac017
Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn’s Disease
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1140–1150, https://doi.org/10.1093/ecco-jcc/jjab236
Tollip Orchestrates Macrophage Polarization to Alleviate Intestinal Mucosal Inflammation
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1151–1167, https://doi.org/10.1093/ecco-jcc/jjac019
Review Article
Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1168–1176, https://doi.org/10.1093/ecco-jcc/jjac013
Viewpoint
The Thiopurine Tale: An Unexpected Journey
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1177–1183, https://doi.org/10.1093/ecco-jcc/jjac004
